Equine Veterinary Journal · 2005 · 51 citations · 18 references
MedicineEndocrinologyVeterinary PhysiologyBone MetabolismEquine MedicineEquine ScienceArticular Cartilage StructureCartilage BiologyCartilage BreakdownCartilage DegenerationCartilage MetabolismSkeletal DevelopmentArticular Cartilage LossCanalsCartilage AgingOsteochondral UnitProtein Structural ChangesPubertal Skeletal DevelopmentPubertal Skeletal GrowthTidemark Morphology
REASONS FOR PERFORMING STUDY: Structural changes in articular cartilage associated with the ageing process require definition for investigators performing developmental and age-related studies, for which information is lacking. OBJECTIVES: To 1) determine the onset and end of puberty as defined by serum insulin like growth factor (IGF-I) and IGF-binding protein-3 (IGFBP-3) concentrations and 2) correlate articular-epiphyseal cartilage complex structural changes with the onset and end of puberty. METHODS: IGF-I and IGFBP-3 were measured in serum samples from normal female and male horses age 9-715 days to determine peak and steady-state values for horses transitioning through puberty. Osteochondral tissue sections were obtained from horses age 120-840 days (4-28 months) and examined histologically for cartilage canals and tidemark formation. RESULTS: In male and female horses, serum IGF-I/IGFBP-3 concentrations peaked at approximately 225 days, defining the onset of puberty. Cartilage canals were absent from articular cartilage just prior to this time point. IGF-I/IGFBP-3 concentrations declined to steady-state levels at approximately age 450 days, signalling exit from puberty and therefore the beginning of ageing. This time point correlated to initial formation of a tidemark in the osteochondral tissue sections. CONCLUSIONS: Horses may be considered pubescent at age 225-450 days, and post pubescent and ageing after age 450 days. POTENTIAL RELEVANCE: Defining the normal post natal to post pubescent concentrations for serum IGF-I and serum IGFBP-3 establishes subsets of animals for age-related studies and may be used to monitor horses for abnormally high IGF-I concentrations due to natural disease or subsequent to systemic growth hormone administration.
18
William H. Daughaday, Ida K. Mariz, Sandra L. Blethen · The Journal of Clinical Endocrinology & Metabolism · 1980 · 745 citations
Eckhard Leifke, Vitali Gorenoi, C. Wichers et al. · Clinical Endocrinology · 2000 · 264 citations
Donald L. Thompson, M.S. Rahmanian, C. L. DePew et al. · Journal of Animal Science · 1992 · 93 citations · Full text